Dermal Cell News Volume 9.38 | Nov 27 2023

    0
    10








    2023-11-27 | DCN 9.38


    Dermal Cell News by STEMCELL Technologies
    Vol. 9.38 – 27 November, 2023
    TOP STORY

    Vector-Borne Trypanosoma brucei Parasites Develop in Artificial Human Skin and Persist As Skin Tissue Forms

    The authors introduced an advanced human skin equivalent and used tsetse flies to naturally infect the skin with trypanosomes.
    [Nature Communications]

    Full Article
    Discover new celli Isolation technologies
    PUBLICATIONSRanked by the impact factor of the journal

    Epidermal–Dermal Coupled Spheroids Are Important for Tissue Pattern Regeneration in Reconstituted Skin Explant Cultures

    Researchers studied cardinal features important for tissue patterning and hair regeneration, finding that they spontaneously formed spheroid configurations, with polarized epidermal cells coupled with dermal cells through a newly formed basement membrane.
    [NPJ Regenerative Medicine]

    Full Article

    Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity – Insights to Anchoring Fibril Homeostasis

    Scientists engineered mice that kept physiological expression of collagen VII only in epithelial cells or in fibroblasts, revealing that production of collagen VII either by keratinocytes or fibroblasts alone was sufficient for creation of mechanically robust skin.
    [Journal Of Investigative Dermatology]

    Abstract

    Machine Learning-Based Morphological Quantification of Replicative Senescence in Human Fibroblasts

    Investigators presented the results of a readily accessible machine learning-based pipeline that used standard fluorescence microscope and open access software to quantify the minute morphological changes that human fibroblasts undergo during their replicative lifespan in culture.
    [Geroscience]

    Abstract

    MiR126-Targeted-Nanoparticles Combined with PI3K/AKT Inhibitor as a New Strategy to Overcome Melanoma Resistance

    Scientists synthesized chitosan nanoparticles containing a chemically modified miR126 sequence, which were further functionalized with an antibody specific to the chondroitin sulfate proteoglycan 4 melanoma marker.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Upregulated Expression of miR-4443 and miR-4488 in Drug Resistant Melanomas Promotes Migratory and Invasive Phenotypes through Downregulation of Intermediate Filament Nestin

    miR-4488 and miR-4443 were measured by qRT-PCR. Nestin levels were tested by western blot, confocal immunofluorescence, immunohistochemical and flow cytometry analyses.
    [Journal Of Experimental & Clinical Cancer Research]

    Full ArticleGraphical Abstract

    Anti-Inflammatory Artificial Extracellular Vesicles with Notable Inhibition of Particulate Matter-Induced Skin Inflammation and Barrier Function Impairment

    In vivo studies revealed that repeated particulate matter exposure to intact skin resulted in cutaneous inflammatory responses, including increased skin thickness and mast cell infiltration.
    [ACS Applied Materials & Interfaces]

    AbstractGraphical Abstract

    Sulforaphane Alleviates Psoriasis by Enhancing Antioxidant Defense through KEAP1-NRF2 Pathway Activation and Attenuating Inflammatory Signaling

    In vitro experiments using HaCaT cells demonstrated that sulforaphane inhibited IL-22 and TNF-α-induced activation of inflammatory pathways and keratinocyte proliferation.
    [Cell Death & Disease]

    Full Article

    Metabolic Re-Programming of Keratinocytes in Response to Contact Allergens

    Primary pooled keratinocytes and a keratinocyte cell line were stimulated with contact allergens, and inflammatory responses and expression of metabolic markers were measured by qPCR and flow cytometry, respectively.
    [Contact Dermatitis]

    Full Article
    An ISSCR 2022 COREdinates Webinar: Differentiation of High-Quality hPSCs Using STEMdiff â„¢ and TeSR â„¢-AOF, presented by Kim Snyder. Click to Watch Now.
    REVIEWS

    Navigating the Landscape of Psoriasis Therapy: Novel Targeted Pathways and Emerging Trends

    The authors focus on intracellular and molecular mechanisms such as AhR, A3AR, RIP1, CGRP, and S1P that serve as novel pharmacological targets for psoriasis, and on new molecules now approved or under clinical investigation to interfere with these target mechanisms.
    [Expert Opinion On Therapeutic Targets]

    Abstract
    INDUSTRY AND POLICY NEWS

    Saudi Universities Lose Highly Cited Researchers after Payment Schemes Raise Ethics Concerns

    The number of top researchers affiliated with universities in Saudi Arabia has dropped sharply, months after the institutions were revealed to be enticing eminent scientists abroad to declare a Saudi affiliation—often in exchange for cash—in a bid to boost their rankings.
    [SCIENCEINSIDER]

    Editorial
    FEATURED EVENT

    PepTalk 2024

    January 16 – 19, 2024
    San Diego, California, United States & Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Anti-Tumor Immunity & Melanoma Biology

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Postdoctoral Researchers – Skin and Mucosa Inflammation, Immunity & Tissue Regeneration

    Temple University – Philadelphia, Pennsylvania, United States

    Research Assistant – Epigenetics

    Babraham Institute – Cambridge, England, United Kingdom

    Postdoctoral Researcher – Cancer Bioinformatics and Immunotherapies

    Armenian Bioinformatics Institute – Yerevan, Armenia

    Postdoctoral Associate – Skin and ECM Biology

    Stony Brook University – Stony Brook, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2